Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)
Clinical trial NCT00765830 · COMPLETED
Trial details
- NCT number
- NCT00765830
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2011-04-01
- Enrollment
- 349
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.